Phase I Study to Assess the Safety and Immunology of a COVID-19 Vaccine With GRAd-COV2 Vaccine
Clinical trial NCT04528641 · COMPLETED
Trial details
- NCT number
- NCT04528641
- Sponsor
- ReiThera Srl
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-10
- Primary completion
- 2021-05-19
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.